The biotechnology company Nattaro Labs AB hereby publishes the year-end report for 2023.
Continue readingMore TagCategory: Press releases
Nattaro Labs AB publishes Interim Report 3, 2023
In 2023, Nattaro will show a significantly improved result. As earlier in the year, sales in the third quarter were at a higher level than last year thanks to increased international sales.
Continue readingMore TagThe Board of Directors of Nattaro Labs resolves on a new share issue of SEK 7 million
The Board of Directors of Nattaro Labs resolves on a new share issue of SEK 7 million and postpones the publication of the interim report for Q3 2023
Continue readingMore TagNattaro Labs AB publishes Interim Report 2, 2023
During the second quarter, Nattaro can show a significantly improved result, both thanks to a higher sales level and the effects of the measures taken for a lower cost base.
Continue readingMore TagNotice of extraordinary general meeting in Nattaro Labs AB (publ)
The shareholders of Nattaro Labs AB are hereby summoned to the Extraordinary General Meeting on Wednesday 6 September 2023 at 16.00 at Medicon Village, Scheeletorget 1, in Lund.
Continue readingMore TagMarket approval and distributor agreement in Chile for Nattaro Labs
Nattaro Labs has received market approval for the company’s patented diatomaceous earth tape Nattaro SafeTM. At the same time, the company announces that it has signed a three-year distributor agreement with the Chilean company Control Integral de Plagas Limitada
Continue readingMore TagNattaro Labs AB publishes Annual Report for 2022
Nattaro Labs AB hereby publishes the Annual Report for the full year 2022.
Nattaro Labs’ first year as a listed company has been challenging. An uncertain world and the hospitality industry’s slow recovery have affected our sales. At the same time, our home market shows enormous international potential. During the fourth quarter, a cost-saving program and a clearer sales strategy were introduced. The start of the new year indicates that we are on the right track.
Nattaro Labs AB publishes Interim Report 1, 2023
Nattaro Labs AB hereby publishes the interim report for the period January – March 2023.
Continue readingMore TagNattaro Labs AB carries out directed share issue
Nattaro Labs AB announces that it has completed a directed share issue of approximately SEK 1.6 million in order to strengthen the Company’s working capital and to add new strategically important shareholders.
Continue readingMore TagApproval for Nattaro Safe in Spain and the Netherlands
Subsequent national registration has been approved for Nattaro Safe in Spain and the Netherlands, which is required for the product to be allowed to be sold in the respective countries.
Continue readingMore Tag